Pasteurized Akkermansia Muciniphila for Weight Management and Energy Metabolism in Overweight and Obesity

This clinical trial explores the potential benefits of using pasteurized Akkermansia muciniphila Akk11, a type of killed bacteria, to help manage weight and improve energy metabolism in adults who are overweight or obese. The study aims to see if these capsules can positively affect various body measurements such as weight, BMI, body fat percentage, waist-hip ratio, wrist circumference, visceral fat area, and basal metabolic rate. Additionally, it investigates whether these capsules can improve blood lipid levels, which include total cholesterol, LDL, HDL, and triglycerides. This research is important because finding effective ways to manage weight and improve metabolic health can significantly enhance quality of life and reduce health risks associated with obesity. Participants in the study will take capsules of either the pasteurized Akkermansia muciniphila Akk11 or a placebo. The effects will be measured by monitoring changes in body composition and blood lipid levels over time. This involves evaluating various parameters like body fat and cholesterol levels, which are critical indicators of metabolic health. Although the study does not specify the phase, it is interventional, meaning it involves active treatment to assess the outcomes. The process is designed to ensure safety and efficacy, providing valuable information on the potential role of this bacterial supplement in managing obesity and metabolic health.